Over the past 15 months, the Singapore state investor committed nearly $4 billion in capital, including its stake in Manipal Healthcare Enterprises. It expects to deploy $9-10 billion within the next three years, the executives said.
Ahmedabad-based Nirma group and leading private equity firms have joined the race to acquire BSE-listed Glenmark Life Sciences.
The acquisition by chemicals-to-cement major Nirma, if successful, would be a major boost for the health-care segment of the group, on the lines of its successful entry into the cement sector following its purchase of Lafarge India's assets for about Rs 9,400 crore in July 2016.
It later followed up by buying Emami cement assets for Rs 5,500 crore in February 2020.